1. Home
  2. UG vs XLO Comparison

UG vs XLO Comparison

Compare UG & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.00

Market Cap

32.9M

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
XLO
Founded
1942
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UG
XLO
Price
$6.00
$0.68
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
14.4K
522.5K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
11.67%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$10,060,322.00
$31,804,000.00
Revenue This Year
N/A
$589.60
Revenue Next Year
N/A
$38.00
P/E Ratio
$14.07
N/A
Revenue Growth
N/A
588.40
52 Week Low
$5.58
$0.62
52 Week High
$11.98
$1.70

Technical Indicators

Market Signals
Indicator
UG
XLO
Relative Strength Index (RSI) 43.84 35.82
Support Level $5.87 $0.68
Resistance Level $6.10 $0.73
Average True Range (ATR) 0.17 0.03
MACD 0.08 -0.00
Stochastic Oscillator 87.49 2.13

Price Performance

Historical Comparison
UG
XLO

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: